GlassScriptPhysician profile
Arun M Kandra
NPI 1376703132
$4,556.80
in general payments reported to CMS, 2019-2025
31 companies · $201 in 2025
The $201 reported for 2025 was more than what 81% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $932 · 2020: $1,040 · 2021: $1,529 · 2022: $376 · 2023: $348 · 2024: $131 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $680.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,188.94 | 2019-2023 | Proclaim |
| Boston Scientific Corporation | $918.04 | 2019-2025 | General - Pain Management |
| Spinal Simplicity, LLC | $447.80 | 2021 | |
| Nevro Corp. | $364.93 | 2019-2020 | |
| Horizon Therapeutics Plc | $309.87 | 2019-2020 | |
| Biotronik Nro, INC. | $283.44 | 2023-2025 | Prospera, Biotronik |
| Collegium Pharmaceutical, INC. | $165.58 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $119.05 | 2019-2022 | |
| Medtronic USA, INC. | $101.17 | 2020 | |
| Scilex Pharmaceuticals INC. | $97.33 | 2019 | |
| Medtronic, INC. | $71.50 | 2021 | |
| Daiichi Sankyo INC. | $62.25 | 2019 | |
| Biodelivery Sciences International, INC. | $55.78 | 2020 | |
| Pfizer INC. | $49.23 | 2019-2021 | |
| Sentynl Therapeutics, INC. | $49.13 | 2019-2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $45.37 | 2019-2024 | Prialt |
| Teva Pharmaceuticals USA, INC. | $22.77 | 2019 | |
| Stimwave Technologies Incorporated | $19.73 | 2019 | |
| Zimmer Biomet Holdings, INC. | $17.02 | 2019 | |
| Bioventus LLC | $16.90 | 2022 | |
| Merck Sharp & Dohme LLC | $15.66 | 2022 | |
| Kaleo, INC. | $14.97 | 2019 | |
| Almatica Pharma LLC | $14.71 | 2021 | |
| Virtus Pharmaceuticals LLC | $14.55 | 2021 | |
| Assertio Therapeutics, INC. | $14.04 | 2019 | |
| Glaxosmithkline, LLC. | $13.80 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $13.45 | 2024 | |
| Shionogi INC | $13.25 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.94 | 2019 | |
| Pacira Therapeutics, INC. | $12.39 | 2019 | |
| Orthogenrx INC. | $11.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arun Kandra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.